RO

Rienk Offringa

BH Bayer Healthcare: 4 patents #2,099 of 8,007Top 30%
DK Deutsches Krebsforschungszentrum: 4 patents #24 of 345Top 7%
BP Bayer Pharma: 2 patents #315 of 819Top 40%
TS Transgene Sa: 1 patents #85 of 144Top 60%
IT Imperial Cancer Research Technology: 1 patents #35 of 66Top 55%
KN Keygene N.V.: 1 patents #49 of 91Top 55%
LC Leiden University Medical Center: 1 patents #11 of 48Top 25%
Overall (All Time): #360,357 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12221479 Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies Jörg Willuda, Mark Trautwein, Hans-Henning BÖHM, Philipp Beckhove 2025-02-11
11998539 Substituted aminoquinolones as DGKalpha inhibitors for immune activation Norbert Schmees, Lars Wortmann, Dennis KIRCHHOFF, Thi Thanh Uyen NGUYEN, Nicolas Werbeck +7 more 2024-06-04
11964953 Substituted aminothiazoles as DGKzeta inhibitors for immune activation Norbert Schmees, Ulrike Roehn, Dennis KIRCHHOFF, Kirstin Petersen, Mareike GREES +3 more 2024-04-23
11427578 Substituted pyrrolopyridine-derivatives Jeffrey Stuart MOWAT, Bernd Buchmann, Nuria Aiguabella Font, Gabriele LEDER, Rafael CARRETERO +5 more 2022-08-30
10253073 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Sjoerd Hendrikus Van Der Burg, Tom H. M. Ottenhoff, Annemieke Geluk, Maria Johanna Philomena Schoenmaekers-Welters, Annemieke M. De Jong +2 more 2019-04-09
9650423 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Sjoerd Hendrikus Van Der Burg, Tom H. M. Ottenhoff, Annemieke Geluk, Maria Johanna Philomena Schoenmaekers-Welters, Annemieke M. De Jong +2 more 2017-05-16
9115185 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Sjoerd Hendrikus Van Der Burg, Tom H. M. Ottenhoff, Annemieke Geluk, Maria Johanna Philomena Schoenmaekers-Welters, Annemieke M. De Jong +2 more 2015-08-25
8663646 P53 peptide vaccine Sjoerd Henricus Van Der Burg, Cornelis Johannes Maria Melief, Gemma G. Kenter 2014-03-04
7892828 Method of identifying a MHC class I restricted T cell response Joyce Taylor-Papadimitriou, Lukas Carl Heukamp, Cornelis Johanna Maria Melief, Bruce Acres, Mireille Thomas 2011-02-22
7807369 Methods and means for the treatment of HPV induced intraepithelial neoplasia Sjoerd Hendricus van der Burg, Cornelis Johannes Maria Melief, Theodorus Jozef Maria Helmerhorst 2010-10-05
7563445 CD40 binding molecules and CTL peptides for treating tumors Cornelis Johannes Maria Melief, Stephen P. Schoenberger, Rene Toes 2009-07-21
7560105 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses Delphine Gabrielle Josette Rea, Cornelis Johannes Maria Melief 2009-07-14
7202034 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Sjoerd Hendrikus Van Der Burg, Tom H. M. Ottenhorf, Annemieke Geluk, Maria Johanna Philomena Schoenmaekers-Welters, Annemieke M. De Jong +2 more 2007-04-10